Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery
UNC Lineberger Comprehensive Cancer Center
UNC Lineberger Comprehensive Cancer Center
UNICANCER
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Memorial Sloan Kettering Cancer Center
University of Chicago
M.D. Anderson Cancer Center
University of Pittsburgh
The Clatterbridge Cancer Centre NHS Foundation Trust
UNICANCER
The Center for Clinical and Cosmetic Research
University of Pittsburgh
Federation Francophone de Cancerologie Digestive
UNC Lineberger Comprehensive Cancer Center
National Taiwan University Hospital
UNC Lineberger Comprehensive Cancer Center
University of Arizona
University of Arizona
Merck Sharp & Dohme LLC
University of Pittsburgh
UNC Lineberger Comprehensive Cancer Center
Pfizer
University of Kentucky
University of Wisconsin, Madison
University of Kentucky
Vidac Pharma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
H. Lee Moffitt Cancer Center and Research Institute
Amgen
Baylor College of Medicine
Heidelberg University
Zagazig University
University of Texas Southwestern Medical Center
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
University Health Network, Toronto
Assistance Publique - Hôpitaux de Paris
University of Texas Southwestern Medical Center
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
UNC Lineberger Comprehensive Cancer Center
University of Rochester
Karolinska University Hospital
M.D. Anderson Cancer Center
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Amgen
Istituto Oncologico Veneto IRCCS
National Cancer Institute (NCI)
Traws Pharma, Inc.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
University of Alabama at Birmingham
Amgen